Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RBM8A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TIAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VDAC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1orf56 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PSMD10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD14D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERF2-C15ORF63 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC25A40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SURF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HRH4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIDA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THBD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on